A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (Q63811669)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus |
clinical trial |
Statements
BRAVE I (English)
0 references
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (English)
0 references
2 August 2018
0 references
21 May 2021
0 references
750
0 references
18 year
0 references